Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Alogliptin (Nesina) and Glipizide (Glucotrol XL) are both medications used to treat Type 2 diabetes, but they work in different ways. Alogliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that helps your body keep insulin around longer and reduces sugar production, while glipizide is a sulfonylurea that signals your pancreas to release more insulin. Alogliptin is typically taken once daily and doesn't usually affect your body weight, whereas glipizide can cause weight gain and may be taken once or twice daily. Glipizide has a higher risk of causing dangerously low blood sugar levels, especially if you skip meals, while alogliptin's common side effects include headaches and cold-like symptoms. Both medications are available as lower-cost generics, but unlike glipizide, alogliptin isn't considered as a first-choice treatment for Type 2 diabetes.
Alogliptin (Nesina)
Glipizide
Alogliptin (Nesina)
Glipizide
Summary of Nesina vs. Glucotrol
Summary for DDP-4 inhibitor
Prescription only
Alogliptin (Nesina) is a medication that treats Type 2 diabetes. It's added to diet and exercise to help lower your blood sugar levels. But it isn't a first-choice treatment for this condition. Alogliptin (Nesina) is typically taken by mouth once a day. Some people may experience certain side effects, such as headaches or symptoms of the common cold (e.g., sore throat or runny nose), after starting this medication.
Summary for Sulfonylurea
Prescription only
Glipizide is a sulfonylurea medication used to treat Type 2 diabetes in adults. It lowers blood sugar levels by telling your pancreas to release more insulin. Glipizide is taken by mouth, typically once or twice daily. Some side effects of this medication include dizziness and diarrhea. Taking glipizide can also put you at risk for dangerously low blood sugar, so it's important to take this medication with meals.